Oncology Drug Updates
On February 16, 2010, a Risk Evaluation and Mitigation Strategies (REMS) program to ensure safe use of erythropoiesis-stimulating agents (ESAs) was approved by the US Food and Drug Administration (FDA).
Supporting Cancer Survivors at Work: We're There When You Need Us
The May 2010 theme of Oncology Nursing Month is “Oncology Nurses: There When You Need Us.”
Helping Patients Access Protections of the ADA
When she learned that she had breast cancer, Patricia Garrett did what many people with cancer do: she continued working.
Osteoporosis in a Young Breast Cancer Survivor
More than 2.5 million breast cancer survivors live in the US today. This number will continue to grow thanks to early detection and advances in treatment that are making early stage breast cancer an increasingly curable disease.
Pazopanib, a Multitargeted Tyrosine Kinase Inhibitor for Advanced Renal Cell Cancer
Approved Drugs: Pazopanib (Votrient) Indications
Cancer and Work: Protections Under the Americans with Disabilities Act
With about 12 million cancer survivors living in the US, cancer affects millions of working Americans. Improvements in early detection and treatment have resulted in a significant number of newly diagnosed and long-term survivors of working age.
Curcumin is yellow curry powder, also called turmeric, Indian saffron, “Haldi,” or “curry powder.” It is a yellow pigment present in turmeric and constitutes 2%–5% of turmeric.
Trouble Sleeping During Breast Cancer Adjuvant Chemotherapy Treatments
The patient, “TB,” is a 44-year-old Caucasian, married woman with three daughters, 21, 18, and 10 years of age.
Screening for Emotional Distress in Older Patients With Lung Cancer
An estimated 219,440 new cases of lung cancer were expected in 2009, accounting for about 15% of cancer diagnoses.
2 Clarke Drive Cranbury, NJ 08512